Astellas Pharma (4503N) Q4 2022 Earnings Report
MX:4503N Q4 2022 EPS Results
- Actual EPS
- -MXN 2.96
- Consensus EPS
- -MXN 2.45
- Beat/Miss
- Missed by -MXN 0.51
- One Year Ago EPS
- MXN 1.88
MX:4503N Q4 2022 Revenue Results
- Actual Revenue
- MXN 41.68B
- Expected Revenue
- MXN 42.52B
- Beat/Miss
- Missed by -MXN 838.03M
- YoY Revenue Growth
- +16.58%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 04/27/2023
- Time
- Before Open
- Conference Call
- Thursday, April 27, 2023
Q4 2022 Earnings Call Audio
MX:4503N Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4503N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q2) | 7.65- | 5.2 | ― | |
| Aug 05, 2026 | 2026 (Q1) | 6.379.31 | 4.5 | 107.09% (+4.82) | |
| Apr 27, 2026 | 2025 (Q4) | 3.602.86 | 4.92 | -41.95% (-2.06) | |
| Feb 04, 2026 | 2025 (Q3) | 5.406.59 | -6.42 | 202.73% (+13.01) | |
| Oct 30, 2025 | 2025 (Q2) | 3.515.20 | 2.36 | 120.44% (+2.84) | |
| Jul 30, 2025 | 2025 (Q1) | 2.344.50 | 2.47 | 82.00% (+2.03) | |
| Apr 25, 2025 | 2024 (Q4) | 2.514.92 | -2.18 | 325.50% (+7.11) | |
| Feb 04, 2025 | 2024 (Q3) | 2.89-6.42 | 1.22 | -624.52% (-7.64) | |
| Oct 30, 2024 | 2024 (Q2) | 2.122.36 | -0.09 | 2607.50% (+2.45) | |
| Aug 01, 2024 | 2024 (Q1) | 1.122.47 | 2.17 | 13.76% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

